Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children's Oncology Group.

Saved in:
Bibliographic Details
Title: Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children's Oncology Group.
Authors: Hazard FK; Department of Pathology, Stanford University School of Medicine, Stanford, California., Toland AMS; Department of Pathology, Stanford University School of Medicine, Stanford, California., Tan SY; Department of Pathology, Stanford University School of Medicine, Stanford, California., Chiu B; Department of Surgery, Stanford University School of Medicine, Stanford, California., Ikegaki N; Department of Anatomy and Cell Biology, University of Illinois, Chicago, Illinois., Naranjo A; Children's Oncology Group Statistics and Data Center, Department of Biostatistics, University of Florida, Gainesville, Florida., Cohn SL; Department of Pediatrics, The University of Chicago, Chicago, Illinois., London WB; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts., Gastier-Foster JM; COG Biospecimen Bank, Biopathology Center, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio.; Institute for Genomic Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio., Ramirez NC; COG Biospecimen Bank, Biopathology Center, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio.; Institute for Genomic Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio., Reshmi SC; COG Biospecimen Bank, Biopathology Center, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio.; Institute for Genomic Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio., Wagner E; COG Biospecimen Bank, Biopathology Center, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio., Nuchtern J; Division of Pediatric Surgery, Department of Surgery, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas., Asgharzadeh S; Division of Hematology/Oncology, Children's Hospital of Los Angeles, Los Angeles, California., Marachelian A; Division of Hematology/Oncology, Children's Hospital of Los Angeles, Los Angeles, California., Maris JM; Department of Pediatrics, Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Bagatell R; Department of Pediatrics, Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Park JR; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee., Irwin MS; Department of Pediatrics, Hospital for Sick Children and Temerty School of Medicine, University of Toronto, Toronto, Canada., Hogarty MD; Department of Pediatrics, Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Shimada H; Department of Pathology, Stanford University School of Medicine, Stanford, California.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2026 Jan 06; Vol. 32 (1), pp. 127-134.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-24-4369